Genocea Biosciences To Present At The Needham & Company 13th Annual Healthcare Conference
4/2/2014 7:57:03 AM
Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-enabled vaccines and immunotherapies, announced today that its president and chief executive officer, Chip Clark, will present a company overview at the Needham & Company 13th Annual Healthcare Conference. The presentation is scheduled for Wednesday, April 9, 2014 at 10:40 a.m. ET at the Westin Grand Central Hotel in New York, NY.
Help employers find you! Check out all the jobs and post your resume.
comments powered by